-
Mohd Salem Mohd Alsbou
- Professor
- Ext: 5356
Dr. Mohammed Al-Sbou is a Professor of Clinical Pharmacology, Pharmacogenomics, and Precision Medicine with over 15 years of progressive experience in teaching and research in the field of clinical pharmacology. He has held several administrative roles, including Vice Dean for Graduate Studies at Mutah University and Assistant Dean for Basic Medical Sciences. Dr. Al-Sbou also served as the Chairman of the Pharmacology Department. He was the Director of the Pharmacovigilance Center for South Jordan at Al-Karak Governmental Teaching Hospital and Vice Chairman of the Health and Hazard Evaluation Committee at the Jordan Food and Drug Administration (JFDA). A Certified Higher Education Quality Assurance Assessor for Medical Institutions at the Higher Education Accreditation and Quality Assurance Commission, Dr. Al-Sbou’s research interests focus on two key areas: pharmacogenomics, precision medicine, and pharmacovigilance, as well as rare genetic disorders. He is the Medical Director and Chairman of the Alkaptonuria Society in Jordan and a member of the International Alkaptonuria Clinical Trial Team (DevelopAKUre Project). Prof. Al-Sbou is also a member of the AKU Society Scientific Advisory Board in the UK, where he contributes to guiding research on Alkaptonuria, fostering international collaboration, reviewing current research initiatives, proposing new directions, and providing feedback on potential clinical trials and drug development programs.
Education
- Doctor of Philosophy (PhD) in Clinical Pharmacology, Department of Pharmacology & Therapeutics, School of Biomedical Sciences, University of Liverpool, United Kingdom, 2007.
- Masters of Science (MSc) in Molecular Pharmacology Physiology, Pharmacology & Toxicology Department, School of Biological Sciences, University of Manchester, United Kingdom, 2003.
- Bachelor of Medicine, Bachelor of General Surgery (MD), Aristotle University of Thessaloniki, Greece, 2000.
Doctor of Philosophy (PhD) in Clinical Pharmacology, Department of Pharmacology & Therapeutics, School of Biomedical Sciences, University of Liverpool, United Kingdom, 2007.
Masters of Science (MSc) in Molecular Pharmacology Physiology, Pharmacology & Toxicology Department, School of Biological Sciences, University of Manchester, United Kingdom, 2003.
Bachelor of Medicine, Bachelor of General Surgery (MD), Aristotle University of Thessaloniki, Greece, 2000.
Experience
- Chairman, Pharmacology Department, Faculty of Medicine, Mutah University, Jordan, 2015–2021.
- Major Physician, Jordanian Royal Medical Services (RMS), Jordanian Armed Forces, Amman, Jordan, 1992–2014.
- Associate Professor in Clinical Pharmacology, Pharmacogenomics, and Precision Medicine, 2012–2017, Department of Pharmacology, Faculty of Medicine, Mutah University, Jordan.
- Vice Dean of Graduate Studies, Faculty of Graduate Studies, Mutah University, Jordan, 2013–2014.
- Director, Pharmacovigilance and Adverse Drug Reaction Center for South Jordan, Jordan Food and Drug Administration (JFDA) / Al-Karak Governmental Teaching Hospital, 2012–2022.
- Assistant Dean for Basic Medical Sciences, Faculty of Medicine, Mutah University, Jordan, 2011–2013.
- Assistant Professor in Clinical Pharmacology, Pharmacogenomics, and Precision Medicine, Department of Pharmacology, Faculty of Medicine, Mutah University, Jordan, 2007–2012.
- Assistant Dean for College Development and Testing Affairs, Faculty of Medicine, Mutah University, Jordan, 2008–2010.
Chairman, Pharmacology Department, Faculty of Medicine, Mutah University, Jordan, 2015–2021.
Major Physician, Jordanian Royal Medical Services (RMS), Jordanian Armed Forces, Amman, Jordan, 1992–2014.
Associate Professor in Clinical Pharmacology, Pharmacogenomics, and Precision Medicine, 2012–2017, Department of Pharmacology, Faculty of Medicine, Mutah University, Jordan.
Vice Dean of Graduate Studies, Faculty of Graduate Studies, Mutah University, Jordan, 2013–2014.
Director, Pharmacovigilance and Adverse Drug Reaction Center for South Jordan, Jordan Food and Drug Administration (JFDA) / Al-Karak Governmental Teaching Hospital, 2012–2022.
Assistant Dean for Basic Medical Sciences, Faculty of Medicine, Mutah University, Jordan, 2011–2013.
Assistant Professor in Clinical Pharmacology, Pharmacogenomics, and Precision Medicine, Department of Pharmacology, Faculty of Medicine, Mutah University, Jordan, 2007–2012.
Assistant Dean for College Development and Testing Affairs, Faculty of Medicine, Mutah University, Jordan, 2008–2010.
Teaching Area
- Clinical Pharmacology
Clinical Pharmacology
Research
- Pharmacogenomics, Precision Medicine, and Pharmacovigilance.
- Rare Genetic Disorders (Alkaptonuria, Phenylketonuria).
Pharmacogenomics, Precision Medicine, and Pharmacovigilance.
Rare Genetic Disorders (Alkaptonuria, Phenylketonuria).
Publications
-
JournalHayaa Banat, Mohammed Alsbou , Nidaa Bawaresh, Faris El-Dahiyat, Jaber Jaber, Khalid awalbeh, Dana Ahmad, Adel Batarseh, Assessment of Knowledge, Attitude, and Practice of Physicians toward Pharmacovigilance in Public and Private Hospitals in Jordan, Jordan Medical Journal, Vol: 56, pp.316 - 327, Oct 2022, doi: https://doi.org/10.35516/jmj.v56i4.468
-
JournalBraconi D, Geminiani M, Psarelli EE, Giustarini D, Marzocchi B, Rossi R, Bernardini G, Spiga O, Gallagher JA, Le Quan Sang KH, Arnoux JB, Imrich R, Al-Sbou MS, Gornall M, Jackson R, Ranganath LR, Santucci A. Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies. Cells. 2022 Nov 18;11(22):3668., MDPI CELLS, Nov 2022
-
JournalEpidemiology of Phenylketonuria Disease in Jordan: Medical and Nutritional Challenges. Safwan Dababneh, Mohammed Alsbou, Nashat Taani , Ghazi Sharkas, Refqi Ismael, Latifeh Maraqa, Omar Nemri, Hanin Al-Jawaldeh, Nadeen Kopti, Enas Atieh and Arab Almasri. MDPI Children. 2022, 9(3):402., MDPI CHILDREN, Feb 2022
Hayaa Banat, Mohammed Alsbou , Nidaa Bawaresh, Faris El-Dahiyat, Jaber Jaber, Khalid awalbeh, Dana Ahmad, Adel Batarseh, Assessment of Knowledge, Attitude, and Practice of Physicians toward Pharmacovigilance in Public and Private Hospitals in Jordan, Jordan Medical Journal, Vol: 56, pp.316 - 327, Oct 2022, doi: https://doi.org/10.35516/jmj.v56i4.468
Knowledge, attitude, and practice toward pharmacovigilance (PV) among healthcare providers is strongly associated with the reporting of adverse drug reactions (ADRs). This study was conducted to evaluate knowledge, attitude, and practice toward pharmacovigilance and to identify barriers for ADR reporting among physicians working in public and private hospitals in Jordan. This study was conducted using an online questionnaire in Arabic, designed by members of the Health Hazard Evaluation Committee of the Jordan Food and Drug Administration (JFDA) between August 2016 to December 2017. The questionnaire was completed using Google Forms online. A total of 341 physicians completed the questionnaire online. The rate of reporting of ADRs is low among physicians as only 4.7% have reported an ADR. The majority of physicians had never heard the term PV before. Respondents also lacked awareness of the existence of a PV center in Jordan and were unaware that ADR monitoring is carried out by the JFDA. Although most of the physicians had never seen the ADR form, many had positive attitudes toward reporting ADRs. According to participant responses, the main barriers to reporting are: 1) not knowing how to report; 2) not knowing the importance of reporting; 3) the unavailability of the ADR form; and, 4) general time pressure in the work environment. Although there is a low rate of ADR reporting among physicians, doctors have a positive attitude toward PV and are willing to implement ADR reporting in their practices. More education and training sessions are needed to raise physician awareness and knowledge of PV, and to enhance ADR reporting.
About the journal
Braconi D, Geminiani M, Psarelli EE, Giustarini D, Marzocchi B, Rossi R, Bernardini G, Spiga O, Gallagher JA, Le Quan Sang KH, Arnoux JB, Imrich R, Al-Sbou MS, Gornall M, Jackson R, Ranganath LR, Santucci A. Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies. Cells. 2022 Nov 18;11(22):3668., MDPI CELLS, Nov 2022
About the journal
Epidemiology of Phenylketonuria Disease in Jordan: Medical and Nutritional Challenges. Safwan Dababneh, Mohammed Alsbou, Nashat Taani , Ghazi Sharkas, Refqi Ismael, Latifeh Maraqa, Omar Nemri, Hanin Al-Jawaldeh, Nadeen Kopti, Enas Atieh and Arab Almasri. MDPI Children. 2022, 9(3):402., MDPI CHILDREN, Feb 2022
About the journal
Conference Presentation
- "Exploring Pharmacogenomics in the MENA Region: Opportunities & Challenges," International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) WorldLab Conference, 8th UAEGDA International Genetic Disorders Conference, Dubai, UAE, May 26–30, 2024.
- "Alkaptonuria: From Basic Research to Clinical Trial – A Success Story from Jordan," MENA Congress for Rare Diseases, Abu Dhabi, May 16–19, 2024.
"Exploring Pharmacogenomics in the MENA Region: Opportunities & Challenges," International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) WorldLab Conference, 8th UAEGDA International Genetic Disorders Conference, Dubai, UAE, May 26–30, 2024.
"Alkaptonuria: From Basic Research to Clinical Trial – A Success Story from Jordan," MENA Congress for Rare Diseases, Abu Dhabi, May 16–19, 2024.
Memberships, Awards and Honors
- Member, Jordanian Medical Association.
- Member, European Association for Clinical Pharmacology.
- Member, International Society of Pharmacovigilance.
- Member, British Pharmacological Society.
- The Daniel Turnberg UK/Middle East Travel Fellowship Scheme, Royal College of Physicians of London and Wellcome Trust, 2011.